Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Go back to Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results| (NASDAQ: LRMR) | Delayed: 4.38 +0.02 (0.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.36 | 52 Week High | $ | |||
| Open | $4.33 | 52 Week Low | $ | |||
| Day High | $4.42 | P/E | N/A | |||
| Day Low | $4.30 | EPS | $ | |||
| Volume | 652,160 | |||||

